Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future

Diabetic kidney disease (DKD) is a leading cause of morbidity and mortality among people living with diabetes, and is one of the most important causes of end stage renal disease worldwide. In order to reduce progression of DKD, important management goals include treatment of hypertension, glycaemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallik, Ritwika, Chowdhury, Tahseen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Diabetic Kidney Disease: Pathogenesis and Therapeutic Targets
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905210/
https://www.ncbi.nlm.nih.gov/pubmed/35281302
http://dx.doi.org/10.1177/20420188221081601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905210/
https://www.ncbi.nlm.nih.gov/pubmed/35281302
http://dx.doi.org/10.1177/20420188221081601

Ejemplares similares